You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

24 January 2022
Information for sponsors regarding the supply of COVID-19 tests, including advice for those sponsors new to therapeutic goods regulation in Australia.
17 January 2022
Updated guidance for businesses using rapid antigen tests approved by the TGA as point-of-care tests
17 January 2022

Find out about the different ways we test for COVID-19 in Australia.

14 January 2022
Important information about the use of COVID-19 point-of-care tests.
12 January 2022

Find out information about the different types of tests and how the TGA assesses them and monitors their performance.

12 January 2022
Answers to frequently asked questions in relation to rapid antigen tests.
17 December 2021
Information about a TGA post-market review of face masks, including guidance for suppliers and users of face masks.
9 December 2021
An overview of the regulation of Personal Protective Equipment (PPE) in Australia, including face masks, gowns and gloves.
9 December 2021
Information relating to face masks and gowns to assist healthcare organisations as they update their operating procedures during the outbreak
8 November 2021
Updated guidance clarifying the interaction between TGA and AHPRA advertising guidelines.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us